India: AYUSH Prohibits Advertisement Of ASU Drugs

The AYUSH Ministry has come up with stringent regulatory guidelines to prevent misleading and inappropriate advertisements of Ayurveda, Siddha and Unani (ASU) medications in the country. On December 21, 2018, the Central Government introduced the eleventh amendment of Drug and Cosmetic Rule, 2018, which addresses 'Prohibition of advertisements of Ayurveda, Siddha or Unani drugs' in public interest.


Till date Drugs and Cosmetics (D&C) Act, 1940, regulates the manufacturing, sale and distribution of ASU medicines under various provisions of Drugs and Cosmetic Rule, 1945, whereas, the Act which regulates the advertisement of prescription-only drugs such as Schedule H, H1 and X to the general public, has not specifically addressed the advertisement of ASU drugs.

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, which regulates the advertisement of 'drug', covers all medicines, substances and articles other than food products. The Act empowers State Government to authorize Gazetted Officers to search, seize, examine any record, register, document or any other material object related to any objectionable advertisement, and analyze and monitor the veracity of misleading advertisements under the provisions of the Act.

At present 22 States have appointed 621 Gazetted officers to enforce the legal provisions for taking necessary actions against the defaulters. Ministry of AYUSH also signed a MoU with Advertising Standards Council of India (ASCI), a self-regulatory voluntary organization of advertising industry for suo-moto monitoring of misleading advertisements of AYUSH drugs appearing in the print media and TV channels and bring the defaulters to the notice of respective State regulators1.

Despite this, the increasing numbers of complaints of misleading advertisement of ASU drugs has been reported in Grievances against Misleading Advertisements (GAMA) portal, Ministry of Consumer Affairs, Food and Public Distribution. Therefore, the AYUSH Ministry, after consultation with the Ayurveda, Siddha and Unani Drugs Technical Advisory Board has introduced Rule 170 in the eleventh amendment of Drugs and Cosmetics Rules, 20182:

Rule 170: Prohibition of advertisements of Ayurveda, Siddha or Unani drugs

The rule restricts ASU drug manufacturers from advertising their products

The manufacturer of Ayurveda, Unani or Siddha shall not participate in the advertisement of any drugs relating to any drug or the use of diagnosis, cure, mitigation, treatment or prevention of any disease, disorder, syndrome or condition.

The advertisement of ASU drugs shall be allowed with conditions

The Ayurveda, Siddha or Unani drug shall be advertised for the purpose other than restricted purpose after the allotment of the Unique Identification Number (UNN).

The manufacturer of the Ayurveda, Siddha or Unani drug shall apply for the Unique Identification Number for the advertisement issued or aired before this notification, within the period of three months from the date of the publication of this notification.

The application of advertisement shall be rejected if:

  • It is incomplete; or
  • the intended advertisement does not contain the contact details of the manufacturer; or
  • the contents of the advertisement directly or indirectly tantamount to vulgarity or obscenity; or
  • it refers to any Ayurvedic, Siddha or Unani drug in terms which suggest or calculated to lead to the use of that drug or medicine for the enhancement of height and dimensions or capacity of performance of male or female sexual organs; or
    • it depicts photographs or testimonials of celebrities or government officials; or
    • it refers to any Government or Autonomous organization of the Government; or
    • it gives a false impression about the true character of Ayurvedic, Siddha or Unani drug; or
    • it makes a misleading or exaggerated claim about the effectiveness of the said drug.

The application procedure for ASU advertisement

The application for the allotment of the unique identification number should be submitted in Form 26 E-4 plus application fee plus other supporting documents to the State Licensing Authority or Drug Controller. The state licensing authority shall process the application within 30 days from the date of receipt of application.

Monitoring misleading Advertisement of ASU drugs

The State Government may notify the officers of ASU system to undertake the monitoring of the advertisements of ASU drugs in the print, electronic, internet and audio-visual media and maintain printed register as well as online register of the advertisements with appropriate entries including those found inappropriate or invalid and action taken against such faulty advertisements and the State Government shall provide information of the advertisements to the Central Government on quarterly basis and also as and when sought by the Central Government.

Note - The Central Government shall, in the public interest, prohibit any advertisement of the Ayurveda, Siddha or Unani drugs, by notification in the Official Gazette.


The amendment provides very precise and clear guidelines to address advertisement of ASU medicines. The manufacturers of the ASU medicines have to abide by these rules and inclusion of the UNN number will play a pivot role in promoting authentic ASU products, and preventing defaulters from misleading public with false claim in their advertisement content.




The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Global Jurix, Advocates & Solicitors
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Global Jurix, Advocates & Solicitors
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions